Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2002
12/05/2002CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002CA2447234A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002CA2411549A1 Ligands of integrin receptors
12/04/2002EP1262477A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
12/04/2002EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002EP1262183A1 Use of norastemizole for the treatment of allergic rhinitis
12/04/2002EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
12/04/2002EP1261731A1 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
12/04/2002EP1261610A2 Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
12/04/2002EP1261602A1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors
12/04/2002EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002EP1261594A1 5,10-dihydroacridines as calcium channel blockers
12/04/2002EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002EP1261585A1 Substituted indole mannich bases
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261356A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1058683B1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/04/2002EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/04/2002CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/03/2002US6489512 Method for making aryl hydrazines and substituted indoles
12/03/2002US6489487 Triazolone derivatives, use thereof, and intermediates therefor
12/03/2002US6489483 Reacting acetyl-substituted pyridine derivative with 3-aminoacrolein, reacting reaction product with ammonia or ammonium salt
12/03/2002US6489479 Process for the preparation of mixed anhydrides
12/03/2002US6489475 Method of producing heterocyclic derivatives
12/03/2002US6489452 An azo dye represented by the following general formula (1) and a process for making the azo dye is disclosed. the process comprises a step in which a diazonium salt is formed by the reaction between an aminopyrazole and aromatic coupling agent
12/03/2002US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002US6489354 In particular, these compounds are useful as modulators of the chemokine receptors ccr-3 and/or ccr-5 useful in the treatment and prevention of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma
12/03/2002US6489346 Substituted benzimidazole dosage forms and method of using same
12/03/2002US6489344 For treatment diabetes in a human or animal subject
12/03/2002US6489342 Aryloxy piperidinyl indoles for treating depression
12/03/2002US6489337 Treatment of alzheimer's disease, epilepsy, eating disorders, learning and memory disorders, migraine, sleep/wake disorders, allergic rhinitis, schizophrenia, mild cognitive impairment, and asthma
12/03/2002US6489327 Tryptase inhibitors
11/2002
11/28/2002WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002WO2002094831A1 Novel pyridylmethylaminopyrimidines
11/28/2002WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002WO2002094815A1 Process for the production of quinazolines
11/28/2002WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002WO2002094807A1 Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine- carboxylate -racemate
11/28/2002WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002WO2002094792A1 Herbicidal substituted benzoylpyrazoles
11/28/2002WO2002094791A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
11/28/2002WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094784A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094782A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002WO2002094267A1 Pharmaceutical composition for prevention or treatment of arthritis
11/28/2002WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002WO2002094178A2 Treatment of renal fibrosis
11/28/2002WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002WO2002078745A3 Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
11/28/2002WO2002078641A3 Pyrrolidine sulfonamides
11/28/2002WO2002057223A3 Compounds azepane, preparation method therefor and pharmaceutical compositions containing said compounds
11/28/2002WO2002048106A3 Isoindolin-1-one glucokinase activators
11/28/2002WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002WO2002000648A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/28/2002US20020177609 Fatty alcohol drug conjugates
11/28/2002US20020177606 Useful as antibiotics against Staphylococcus, Streptococcus, Enterococcus and Moraxella
11/28/2002US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002US20020177593 Non-carbamate amine acetylcholinesterase inhibitor and a carrier; for example, 9-amino-1,2,3,4-tetrahydroacridine or 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo(3,2,1-ij)quinolin-4-one
11/28/2002US20020177588 Selectivity
11/28/2002US20020177587 Treating sexual dysfunction including erectile dysfunction, diabetes melitus, gastrointestinal disorders, including gastric paresis and cardiovascular disorders; cyclic guanosine 3',5'-monophosphate (cGMP)
11/28/2002US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002US20020177559 Inhibitors of cellular efflux pumps of microbes
11/28/2002DE10138577A1 New 4-benzoyl-5-oxy-pyrazole derivatives, useful as herbicides, especially pre- and post-emergence selective herbicides
11/28/2002DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002DE10123574A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/28/2002DE10123573A1 New anthranilamide derivatives and analogs containing heterocycle N-oxide group, as KDR/FLT tyrosine kinase inhibitors, used for e.g. treating psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/28/2002CA2449442A1 Combination medicament for treatment of neoplastic diseases
11/28/2002CA2448449A1 Treatment of renal fibrosis
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2447675A1 Novel pyridylmethylaminopyrimidines
11/28/2002CA2447674A1 Herbicidal substituted benzoylpyrazoles
11/28/2002CA2447233A1 Process for the production of quinazolines
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2446516A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446332A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
1 ... 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 ... 1080